Imiquimod in Children With Plaque Morphea

PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Scleroderma, Localized
Interventions
DRUG

Imiquimod 5% cream

Treatment will last for 36 weeks. Patients will be instructed to apply Imiquimod three times per week for 4 weeks. If no local side effects are noted at the 4 week- follow-up visit, the frequency of the application will be increased to 5 weekly applications.

Trial Locations (1)

M5G 1X8

The Hospital for Sick Children, Toronto

All Listed Sponsors
lead

The Hospital for Sick Children

OTHER

NCT00147771 - Imiquimod in Children With Plaque Morphea | Biotech Hunter | Biotech Hunter